- Company
- Laxxon Medical Corp., a privately held drug development company
- Founded
- 2017
- Headquarters
- 261 Madison Avenue, 9th Floor, New York, NY 10016, USA
- Research and development
- Laxxon Medical GmbH, Jena, Germany
- Intellectual property
- Laxxon's IP is continuously growing, and together with the licensed IP from Exentis Group, consists of 230 patents and patent applications with more than 5,500 patent claims.
- Technology
- Since 2017, Laxxon has held the exclusive worldwide license from Exentis Group AG and Exentis Knowledge GmbH for pharmaceutical applications of the technology behind SPID®.
- CEO and Chairman
- Helmut Kerschbaumer